Malignant Neoplasm of Stomach Completed Phase 2 Trials for G17DT (DB04914)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02233712Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.Treatment
NCT02450032Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric CancerTreatment
NCT02518529Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer PatientsTreatment
NCT02521649Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric CancerTreatment